Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Wuxi Orui Biomedical Technology Co., Ltd., established on 2008-06-12, Business scope includes research on biomedical technology,to develop,Consulting services for transfer and related technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

Institute of Laboratory Animal Science, a subsidiary of University of Zurich, is a Swiss company located in Schlieren that provides research, services and teaching in translational and basic research.

Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Jichi Medical University (自治医科大学 Jichi ika daigaku) is a private university in Shimotsuke, Tochigi, Japan, established in 1972. In 2008 the Gates Foundation awarded $100,000 to Hiroyuki Matsuoka, a medical researcher at the university, to do research on flying syringes.

Shenzhen Licong Biotechnology Co., Ltd., established on 2021-04-01, Business scope includes general business items:Sales of experimental equipment and consumables;Detection Reagent,Biological product(Does not contain drugs)technology development and sales;Domestic Trade(Does not contain franchise,Exclusive control,Monopoly);Import and export of goods and technology(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:biotechnology product(Does not contain drugs)production.

Zhejiang Tongben Technology Co., Ltd., established on 2021-11-11, Business scope includes general items:Research and development of intelligent robots;Internet of things technology research and development;Motor and its control system research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Business Management Consulting;Information Consulting Service(Not including licensing information consulting services);Intelligent control system integration;Industrial automatic control system device manufacturing;Engineering and Technology Research and Experimental Development;software development;software sales;Sales of electronic components and electromechanical components;electronics sales;AI Hardware Sales;Retailing of computer software, hardware and auxiliary equipment;Communication equipment sales;Office Supplies Sales;battery sales;Technology Import and Export;Import and export;(Excluding economic information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Guangdong Yaokang Biotechnology Co., Ltd., established on 2018-10-26, Business scope includes general items:Manufacturing of experimental analysis instruments;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Experimental animal litter production;Experimental analysis instrument sales;Laboratory Animal Bedding Sales;Laboratory animal cage sales;Engineering and Technology Research and Experimental Development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Medical Research and Experimental Development;Information Consulting Service(Not including licensing information consulting services);Sales of Class I Medical Devices;Domestic trade agent;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;pharmaceutical production;Experimental animal production;Experimental animal management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Sichuan Academy of Chinese Medicine Sciences, a subsidiary of Province of Sichuan, is a company headquartered in China that manufactures medicinal chemicals.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.